As of 2024-12-15, the Fair Value of Atea Pharmaceuticals Inc (AVIR) is -51.51 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.93 USD, the upside of Atea Pharmaceuticals Inc is -1,857.87%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -14.00 | -10.90 | 121.20 | -115.90 | -135.96 | -31.11 |
| YoY growth | -53.85% | 22.14% | 1,211.93% | -195.63% | -17.30% | 193.46% |
| Market Cap (mil) | 247.47 |
| P/E | |
| Forward P/E |
| EPS | -2.06 |
| Avg earnings growth rate | 193.46% |
| TTM earnings | -174.01 |